Biomarkers Market by Product, Type & Applications - 2023

By -
A biological marker, commonly known as a biomarker, measures and evaluates biological and pathogenic processes. It also measures pharmacological responses to a therapeutic intervention. Biomarkers are used in predictions, cause, diagnosis, progression, regression and outcome of various diseases. Biomarkers can be specific cell, molecules, genes, gene products, enzymes, hormones, complex organ functions, and general characteristic changes in biological structure.

Factors such as rising demand of personalized medicine, and companion diagnostics are some of the major growth drivers for the global biomarker market. Recent advancements in the discovery technologies such as genome sequencing are also contributing to the overall growth of the global biomarker market. Increasing personalized solution for cancer treatment, and prevention, rising interdisciplinary systems biology approach and development of OMICS technology is expected to drive the market during the forecast period. 
High validation cost and high capital requirement for the discovery and development of biomarkers in drug developments are some of the major factors hindering the biomarkers market. Ethical and early diagnosis of the fatal diseases such as cancer and HIV are some major challenge for the biomarker market.

Based on the various services the global biomarker market can be segmented as clinical, and bioinformatics. Clinical segment can be further classified as sample preparation, assay development, and biomarkers validation & testing. Based on the various applications of biomarkers the global biomarkers market can be bifurcated as drug discovery & development, personalized medicine, and molecular diagnostics. The clinical trials segment can be further bifurcated as preclinical development phase I drug development, phase II drug development, phase III drug development, and phase IV drug development.

Based on the various diseases the global biomarkers market can be segmented as an oncology biomarkers market, cardiology biomarkers market, neurology biomarkers market, other indications biomarkers market, HIV, renal failure, arthritis, tuberculosis, and diabetes. 
Some of the major players operating in the global biomarkers market include, Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc., Dickinson and Company, Becton, Celera Corporation., Epigenomics AG., Bruker Corporation, DiagnoCure Inc., GE Healthcare, Siemens AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Clarient Inc., hermo Fisher Scientific, Inc., Epistem Ltd., and Aushon BioSystem Inc.,
Get More Information Visit:  P&S Market Research 
Report Coverage

  • Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
  • Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
  • Uncovers potential demands in the market
  • Porter analysis identifies competitive forces within the market
  • Provides information on the historical and current market size and the future potential of the market
  • Provides sizes of key regional markets using yardsticks of segments, applications, and segments of applications
  • Highlights the competitive scenario of the market, major competitors, and benchmarking
  • Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics. Profiles provide better understanding of competition as well as the demands of the market.
    Location: Unnamed Road, Boise City, OK 73933, USA

    Comments

    Post a Comment

    Popular posts from this blog

    Hospital Bed Market by Type, Treatment, Geography – Market Size, Growth and Demand

    By -
    Image
    Global hospital bed market is forecasted to attain a size of $4.6 billion by 2023, according to P&S Market Research.The market is mainly driven by the increasing prevalence of chronic diseases, growing healthcare expenditure, surging aging population, and development of advanced hospital bed solutions. Based on the type of bed, the hospital bed market has been categorized into general, birthing, pediatric, pressure relief, and others. Of all types, the fastest growth during the forecast period in the global market is expected from general beds, with 5.8% CAGR, due to their low cost as compared to other beds. Based on treatment, the market has been categorized into acute care, critical care, and long-term care beds. During the forecast period, the hospital bed market for critical care is expected to grow the fastest among all types, with a CAGR of 6.0%. This growth is attributed to the fact that critical-care beds allow lateral tilting of patients, which helps in blood circula...
    Read more

    How the Patient Handling Equipment Market Has Witnessed Substantial Growth in Coming Years?

    By -
    Image
    A report by the United Nations Department of Economic and Social Affairs said that the global population of people in the 60 and above age group is rising rapidly. By the end of 2050, the global share of this age group is expected to grow to 21.1% from 11.7% in 2013. Additionally, the number of people in this age group is predicted to be around 324 million in India, 437 million in China, 58 million in Brazil, and 107 million in the U.S. by 2050. One of the major contributors of the growing elderly population is the increasing life expectancy rate.  Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/patient-handling-equipment-market/report-sample Taking care of the bed-ridden patients or patients with restricted mobility can be taxing for caregivers. They have to perform many tasks, such as lifting, transferring them from one place to another, repositioning, bathing, and dressing a patient. Manual lifting of patients is one of the major risk factors...
    Read more

    Facial Skin Ablative Treatment Market To Reach $8,394.3 Million by 2030

    By -
    Image
     Drivers such as the booming geriatric population, surging number of aesthetic procedures, growing awareness regarding advanced aesthetic treatments, and increasing technological advancements will facilitate the facial skin ablative treatment market growth at a CAGR of 7.8% during the forecast period (2020–2030). The market was valued at $4,134.6 million in 2019, and it is expected to reach $8,394.3 million by 2030 . With the increasing focus on improved appearances, the demand for energy-based aesthetic treatments will amplify in the coming years. The increasing awareness regarding aesthetic procedures, on account of the rising number of exhibitions, seminars, and conferences aimed at generating awareness among the general public and healthcare professionals about the developments in aesthetic and cosmetic treatments will act as a catalyst for the market growth. For example, EuroMediCom (Informa Group) organized the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Apri...
    Read more